WuXi buys NextCODE; Alnylam and Isis re-up their RNA alliance;

@FierceBiotech: Incyte, Agenus partner on immuno-oncology targets in $410M deal. More | Follow @FierceBiotech

@JohnCFierce: Hey, UK readers. I'm moderating a panel Feb 4 at the Queen Mary Innovation Centre on #biotech finance. Invite only. More | Follow @JohnCFierce

@DamianFierce: Biogen signs a $30M deal with Columbia U. to sequence the genomes of "unusual" patients. Release | Follow @DamianFierce

> Chinese CRO WuXi PharmaTech ($WX) bought NextCODE Health for $65 million in cash, bolstering its genomics heft by integrating the deCODE spinout. News

> Alnylam Pharmaceuticals ($ALNY) and Isis Pharmaceuticals ($ISIS) have extended the RNA-focused partnership, cross-licensing their intellectual property to develop new targeted therapeutics. More

> Regeneron ($REGN) and Sanofi ($SNY) say alirocumab, their in-development cardio drug, performed well as a once-a-month therapy for high cholesterol. Item

Medical Device News

@FierceMedDev:  PureTech bumps its early life science funds up to $107M. Story | Follow @FierceMedDev

@EmilyWFierce: Adaptive Biotechnologies snatches up Sequenta to gain ground in cancer immunosequencing Story | Follow @EmilyWFierce

> In a win for Spectranetics, Covidien's to-be-divested drug-coated balloon earns CE mark. News

> C.R. Bard pushes for delay of vaginal mesh trial after judge's call for settlement. Article

Pharma News

@FiercePharma: Catterton offloads PetVet hospital network to Canadian pension plan for $440M. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Court to give speedy answer in Actavis bid to yank old Namenda off market. Report | Follow @CarlyHFierce

> Generics could sink AbbVie below analysts' 2015 estimates. Report

> FDA draws line in sand over its orphan drug policies. Article

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.